Ingvild Ulsaker-Janke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ingvild Ulsaker-Janke has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Cecilie Lund Vestergaard
Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
2 shared publications - Gunnar Morken
Department of Mental Health, St Olav University Hospital, Trondheim, Norway
2 shared publications - Håvard Kallestad
Department for Research and Development, St. Olavs Hospital PH, Trondheim, Norway
2 shared publications Kaia Kjørstad
Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
2 shared publications- Knut Langsrud
Østmarka Psychiatric Department, St. Olavs Hospital PH, Trondheim, Norway
2 shared publications Melanie Rae Simpson
Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
2 shared publications
Latest Publications
- Open Access
- 6 December 2024
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 21 (12) , e1004380
Clinical benefits of modifying the evening light environment in an acute psychiatric unit: A single-centre, two-arm, parallel-group, pragmatic effectiveness randomised controlled trial
Background: The impact of light exposure on mental health is increasingly recognised. Modifying inpatient evening light exposure may be a low-intensity intervention for mental disorders, but few randomised controlled trials (RCTs) exist. We report a large-scale pragmatic effectiveness RCT exploring whether individuals with acute psychiatric illnesses experience additional benefits from admission to an inpatient ward where changes in the evening light exposure are integrated into the therapeutic environment. Methods and findings: From 10/25/2018 to 03/29/2019, and 10/01/2019 to 11/15/2019, all adults (≥18 years of age) admitted for acute inpatient psychiatric care in Trondheim, Norway, were randomly allocated to a ward with a blue-depleted evening light environment or a ward with a standard light environment. Baseline and outcome data for individuals who provided deferred informed consent were used. The primary outcome measure was the mean duration of admission in days per individual. Secondary outcomes were estimated mean differences in key clinical outcomes: Improvement during admission (The Clinical Global Impressions Scale–Improvement, CGI-I) and illness severity at discharge (CGI-S), aggressive behaviour during admission (Broset Violence Checklist, BVC), violent incidents (Staff Observation Aggression Scale-Revised, SOAS-R), side effects and patient satisfaction, probabilities of suicidality, need for supervision due to suicidality, and change from involuntary to voluntary admission. The Intent to Treat sample comprised 476 individuals (mean age 37 (standard deviation (SD) 13.3); 193 (41%) were male, 283 (59%) were female). There were no differences in the mean duration of admission (7.1 days for inpatients exposed to the blue-depleted evening light environment versus 6.7 days for patients exposed to the standard evening light environment; estimated mean difference: 0.4 days (95% confidence interval (CI) [−0.9, 1.9]; p = 0.523). Inpatients exposed to the blue-depleted evening light showed higher improvement during admission (CGI-I difference 0.28 (95% CI [0.02, 0.54]; p = 0.035), Number Needed to Treat for clinically meaningful improvement (NNT): 12); lower illness severity at discharge (CGI-S difference −0.18 (95% CI [−0.34, −0.02]; p = 0.029), NNT for mild severity at discharge: 7); and lower levels of aggressive behaviour (difference in BVC predicted serious events per 100 days: −2.98 (95% CI [−4.98, −0.99]; p = 0.003), NNT: 9). There were no differences in other secondary outcomes. The nature of this study meant it was impossible to blind patients or clinical staff to the lighting condition. Conclusions: Modifying the evening light environment in acute psychiatric hospitals according to chronobiological principles does not change duration of admissions but can have clinically significant benefits without increasing side effects, reducing patient satisfaction or requiring additional clinical staff. Trial registration: Clinicaltrials.gov NCT03788993; 2018 (CRISTIN ID 602154).
- 6 December 2024
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 21 (12) , e1004380
Open AccessClinical benefits of modifying the evening light environment in an acute psychiatric unit: A single-centre, two-arm, parallel-group, pragmatic effectiveness randomised controlled trial
Background: The impact of light exposure on mental health is increasingly recognised. Modifying inpatient evening light exposure may be a low-intensity intervention for mental disorders, but few randomised controlled trials (RCTs) exist. We report a large-scale pragmatic effectiveness RCT exploring whether individuals with acute psychiatric illnesses experience additional benefits from admission to an inpatient ward where changes in the evening light exposure are integrated into the therapeutic environment. Methods and findings: From 10/25/2018 to 03/29/2019, and 10/01/2019 to 11/15/2019, all adults (≥18 years of age) admitted for acute inpatient psychiatric care in Trondheim, Norway, were randomly allocated to a ward with a blue-depleted evening light environment or a ward with a standard light environment. Baseline and outcome data for individuals who provided deferred informed consent were used. The primary outcome measure was the mean duration of admission in days per individual. Secondary outcomes were estimated mean differences in key clinical outcomes: Improvement during admission (The Clinical Global Impressions Scale–Improvement, CGI-I) and illness severity at discharge (CGI-S), aggressive behaviour during admission (Broset Violence Checklist, BVC), violent incidents (Staff Observation Aggression Scale-Revised, SOAS-R), side effects and patient satisfaction, probabilities of suicidality, need for supervision due to suicidality, and change from involuntary to voluntary admission. The Intent to Treat sample comprised 476 individuals (mean age 37 (standard deviation (SD) 13.3); 193 (41%) were male, 283 (59%) were female). There were no differences in the mean duration of admission (7.1 days for inpatients exposed to the blue-depleted evening light environment versus 6.7 days for patients exposed to the standard evening light environment; estimated mean difference: 0.4 days (95% confidence interval (CI) [−0.9, 1.9]; p = 0.523). Inpatients exposed to the blue-depleted evening light showed higher improvement during admission (CGI-I difference 0.28 (95% CI [0.02, 0.54]; p = 0.035), Number Needed to Treat for clinically meaningful improvement (NNT): 12); lower illness severity at discharge (CGI-S difference −0.18 (95% CI [−0.34, −0.02]; p = 0.029), NNT for mild severity at discharge: 7); and lower levels of aggressive behaviour (difference in BVC predicted serious events per 100 days: −2.98 (95% CI [−4.98, −0.99]; p = 0.003), NNT: 9). There were no differences in other secondary outcomes. The nature of this study meant it was impossible to blind patients or clinical staff to the lighting condition. Conclusions: Modifying the evening light environment in acute psychiatric hospitals according to chronobiological principles does not change duration of admissions but can have clinically significant benefits without increasing side effects, reducing patient satisfaction or requiring additional clinical staff. Trial registration: Clinicaltrials.gov NCT03788993; 2018 (CRISTIN ID 602154).
- Open Access
Clinical benefits of modifying the evening light environment in an acute psychiatric unit: A single-centre, two-arm, parallel-group, pragmatic effectiveness randomised controlled trial
Background: The impact of light exposure on mental health is increasingly recognized. Modifying inpatient evening light exposure may be a low-intensity intervention for mental disorders, but few randomized controlled trials (RCTs) exist. We report a large-scale pragmatic effectiveness RCT exploring whether individuals with acute psychiatric illnesses experience additional benefits from admission to an inpatient ward where changes in the evening light exposure are integrated into the therapeutic environment. Methods and findings: All adults admitted for acute inpatient psychiatric care over eight months were randomly allocated to a ward with a blue-depleted evening light environment or a ward with standard light environment. Baseline and outcome data from individuals who provided deferred informed consent were used to analyze the primary outcome measure (differences in duration of hospitalization) and secondary measures (differences in key clinical outcomes). The Intent to Treat sample comprised 476 individuals (mean age 37; 41% were male). There were no differences in the mean duration of hospitalization (6.7 vs. 7.1 days). Inpatients exposed to the blue-depleted evening light showed higher improvement during admission (Clinical Global Impressions scale-Improvement: 0.28, 95% CI: 0.02 to 0.54; p=0.035, Number Needed to Treat for clinically meaningful improvement (NNT): 12); lower illness severity at discharge (Clinical Global Impressions Scale-Severity: –0.18, 95% CI: –0.34 to – 0.02; p=0.029, NNT for mild severity at discharge: 7); and lower levels of aggressive behaviour (Broset Violence Checklist difference in predicted serious events per 100 days: –2.98; 95% CI: –4.98 to –0.99; p=0.003, NNT: 9). Incidents of harm to self or others, side effects, and patient satisfaction did not differ between the lighting conditions. Conclusions: Modifying the evening light environment in acute psychiatric hospitals according to chronobiological principles does not change duration of hospitalizations, but can have clinically significant benefits without increasing side effects, reducing patient satisfaction or requiring additional clinical staff.
Open AccessClinical benefits of modifying the evening light environment in an acute psychiatric unit: A single-centre, two-arm, parallel-group, pragmatic effectiveness randomised controlled trial
Background: The impact of light exposure on mental health is increasingly recognized. Modifying inpatient evening light exposure may be a low-intensity intervention for mental disorders, but few randomized controlled trials (RCTs) exist. We report a large-scale pragmatic effectiveness RCT exploring whether individuals with acute psychiatric illnesses experience additional benefits from admission to an inpatient ward where changes in the evening light exposure are integrated into the therapeutic environment. Methods and findings: All adults admitted for acute inpatient psychiatric care over eight months were randomly allocated to a ward with a blue-depleted evening light environment or a ward with standard light environment. Baseline and outcome data from individuals who provided deferred informed consent were used to analyze the primary outcome measure (differences in duration of hospitalization) and secondary measures (differences in key clinical outcomes). The Intent to Treat sample comprised 476 individuals (mean age 37; 41% were male). There were no differences in the mean duration of hospitalization (6.7 vs. 7.1 days). Inpatients exposed to the blue-depleted evening light showed higher improvement during admission (Clinical Global Impressions scale-Improvement: 0.28, 95% CI: 0.02 to 0.54; p=0.035, Number Needed to Treat for clinically meaningful improvement (NNT): 12); lower illness severity at discharge (Clinical Global Impressions Scale-Severity: –0.18, 95% CI: –0.34 to – 0.02; p=0.029, NNT for mild severity at discharge: 7); and lower levels of aggressive behaviour (Broset Violence Checklist difference in predicted serious events per 100 days: –2.98; 95% CI: –4.98 to –0.99; p=0.003, NNT: 9). Incidents of harm to self or others, side effects, and patient satisfaction did not differ between the lighting conditions. Conclusions: Modifying the evening light environment in acute psychiatric hospitals according to chronobiological principles does not change duration of hospitalizations, but can have clinically significant benefits without increasing side effects, reducing patient satisfaction or requiring additional clinical staff.
- Open Access
- 2 October 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (41)
Grid cells in rats deprived of geometric experience during development
The medial entorhinal cortex (MEC) is part of the brain’s network for dynamic representation of location. The most abundant class of neurons in this circuit is the grid cell, characterized by its periodic, hexagonally patterned firing fields. While in developing animals some MEC cell types express adult-like firing patterns already on the first exposure to an open spatial environment, only days after eye opening, grid cells mature more slowly, over a 1-to-2-wk period after the animals leave their nest. Whether the later emergence of a periodic grid pattern reflects a need for experience with spatial environments has not been determined. We here show that grid-like firing patterns continue to appear during exploration of open square environments in rats that are raised for the first months of their life in opaque spherical environments, in the absence of stable reference boundaries to guide spatial orientation. While strictly periodic firing fields were initially absent in these animals, clear grid patterns developed after only a few trials of training. In rats that were tested in the same open environment but raised for the first months of life in opaque cubes, with sharp vertical boundaries, grid-like firing was from the beginning indistinguishable from that of nondeprived control animals growing up in large enriched cages. Thus, although a minimum of experience with peripheral geometric boundaries is required for expression of regular grid patterns in a new environment, the effect of restricted spatial experience is overcome with short training, consistent with a preconfigured experience-independent basis for the grid pattern.
- 2 October 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (41)
Open AccessGrid cells in rats deprived of geometric experience during development
The medial entorhinal cortex (MEC) is part of the brain’s network for dynamic representation of location. The most abundant class of neurons in this circuit is the grid cell, characterized by its periodic, hexagonally patterned firing fields. While in developing animals some MEC cell types express adult-like firing patterns already on the first exposure to an open spatial environment, only days after eye opening, grid cells mature more slowly, over a 1-to-2-wk period after the animals leave their nest. Whether the later emergence of a periodic grid pattern reflects a need for experience with spatial environments has not been determined. We here show that grid-like firing patterns continue to appear during exploration of open square environments in rats that are raised for the first months of their life in opaque spherical environments, in the absence of stable reference boundaries to guide spatial orientation. While strictly periodic firing fields were initially absent in these animals, clear grid patterns developed after only a few trials of training. In rats that were tested in the same open environment but raised for the first months of life in opaque cubes, with sharp vertical boundaries, grid-like firing was from the beginning indistinguishable from that of nondeprived control animals growing up in large enriched cages. Thus, although a minimum of experience with peripheral geometric boundaries is required for expression of regular grid patterns in a new environment, the effect of restricted spatial experience is overcome with short training, consistent with a preconfigured experience-independent basis for the grid pattern.